Titelia

Holdings of Affinity Asset Advisors, LLC

76 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 46.5 % of the equity sleeve

Sector breakdown

  • Health care 5.8 %
  • Unattributed 94.2 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 90.7 %
  • FR 3.3 %
  • IL 3.1 %
  • DK 1.6 %
  • KY 0.8 %
  • GB 0.4 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US701.2B $90.71 %
FR145.1M $3.31 %
IL142.2M $3.09 %
DK121.7M $1.59 %
KY211.5M $0.84 %
GB16.1M $0.45 %

Positions

CompanySharesValueWeight
Apogee Therapeutics Inc 1,284,926108.2M $
Erasca Inc 5,350,00086.6M $
Insmed Inc 480,00078.5M $
Spyre Therapeutics Inc 1,279,13464.5M $
CENTESSA PHARMACEUTICALS PLC 1,400,00055.6M $
Praxis Precision Medicines Inc 170,00054.8M $
AnaptysBio Inc 940,00052.1M $
Cytokinetics Inc 700,48346.2M $
Abivax SA 405,00045.1M $
Teva Pharmaceutical Industries Ltd 1,400,00042.2M $
Arcellx Inc 362,76441.7M $
Nuvalent Inc 300,00030.7M $
Terns Pharmaceuticals Inc 562,63129.7M $
Dianthus Therapeutics Inc 350,00029.4M $
Lexeo Therapeutics Inc 5,050,21129M $
Cogent Biosciences Inc 750,00028.9M $
Madrigal Pharmaceuticals Inc 55,00028.8M $
Sutro Biopharma Inc 1,069,51926.6M $
Forte Biosciences Inc 1,011,89026.2M $
Oruka Therapeutics Inc 499,67324.5M $
Trevi Therapeutics Inc 2,000,17223.9M $
Ovid therapeutics Inc 10,636,31823.6M $
Enliven Therapeutics Inc 586,90423M $
Ascendis Pharma A/S 95,00021.7M $
Mineralys Therapeutics Inc 750,00020.3M $
AVALO THERAPEUTICS INC 1,340,84020M $
Protagonist Therapeutics Inc 172,12518.1M $
Celldex Therapeutics Inc 500,00015.9M $
Nurix Therapeutics Inc 967,62015M $
Savara Inc 2,512,15313.7M $
Perspective Therapeutics Inc 3,164,58213.2M $
Arrowhead Pharmaceuticals Inc 200,00012.5M $
DAMORA THERAPEUTICS INC 450,00011.7M $
Alto Neuroscience Inc 500,00011.2M $
Bridgebio Pharma Inc 150,00011.1M $
Cullinan Therapeutics Inc 781,26011.1M $
Belite Bio Inc 65,00010.4M $
Vera Therapeutics Inc 250,00010.1M $
Tyra Biosciences Inc 257,5129.9M $
Revolution Medicines Inc 100,0009.7M $
JADE BIOSCIENCES INC 639,9569M $
Travere Therapeutics Inc 300,0008.9M $
Korro Bio Inc 706,9048M $
SpyGlass Pharma Inc 250,0006.5M $
Compass Pathways plc 1,108,4836.1M $
IBIO INC 3,107,2005.9M $
Anteris Technologies Global Corp 912,3975.1M $
Viridian Therapeutics Inc 250,0004.9M $
Climb Bio Inc 700,0004.8M $
Rezolute Inc 1,547,6414.7M $
Sagimet Biosciences Inc 868,0204.5M $
MBX Biosciences Inc 150,0004.5M $
Taysha Gene Therapies Inc 1,000,0004.5M $
VeraDermics Inc 70,0004.4M $
Generate Biomedicines Inc 350,0004.4M $
ArriVent Biopharma Inc 175,0004M $
Relay Therapeutics Inc 400,0004M $
Verrica Pharmaceuticals Inc 707,3383.7M $
Precision BioSciences Inc 597,9463.3M $
Karyopharm Therapeutics Inc 500,0002.8M $
Crinetics Pharmaceuticals Inc 75,0002.7M $
NextCure Inc 241,8262.6M $
Immunovant Inc 100,0002.5M $
Equillium Inc 1,226,3102.5M $
SAB Biotherapeutics Inc 575,0002.2M $
Corcept Therapeutics Inc 50,0002M $
Orchestra BioMed Holdings Inc 402,5501.7M $
Kezar Life Sciences Inc 229,0761.7M $
MacroGenics Inc 500,0001.4M $
Adlai Nortye Ltd. 164,7481.1M $
Alector Inc 500,0001.1M $
OnKure Therapeutics Inc 240,963997.6K $
LENZ Therapeutics Inc 100,000915K $
X4 PHARMACEUTICALS INC 145,000598.9K $
Q32 Bio Inc 27,777178.3K $
ADAGIO MEDICAL HOLDINGS INC 80,00092K $